Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Determinants of Circulating Tumor HPV DNA in Surgically Treated Oropharyngeal Cancer.

A retrospective cohort examined which clinicopathologic features were associated with circulating tumor HPV DNA before and after upfront surgery for HPV-mediated oropharyngeal cancer.

JAMA Otolaryngology–Head & Neck SurgeryPubMed 41926134DOI 10.1001/jamaoto.2026.0015